🔗 Share this article

An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Investigational Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Viewers are encouraged to message these profiles directly for source information, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a robust market exists on messaging services, where groups with numerous of members share comparison images, administration instructions and claims of rapid UK delivery. Vendors market the substance there before redirecting customers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Worries

However, doctors and chemists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in individuals injecting products of unknown origin.

Some professionals stated the demand for retatrutide could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Some content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or imprisonment.

Service Response and Material Removal

Based on the social media company, the service has taken down problematic material and banned related keywords and search suggestions. The organization stated it was committed to keeping the service secure and allocating resources in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also found communities with up to nine thousand members selling retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, filled with images of weight loss, positive reviews and step-by-step instructions for mixing or administering at home.

After minutes of joining one group, a vendor posted contact information, where most purchases take place. The seller provided an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or past usage.

Product Information and Costs

Inside these groups, messages display dark colored packages with Royal Mail stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When asked how much time a injector should be used, vendors give contradictory answers varying between a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service said it regularly monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering substances they can’t verify. Even if the research behind retatrutide is sound, these online products may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.

Her staff has previously encountered individuals injured by personal administration from unverified suppliers. “We understand the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may expose users to potentially significant health risks”.